probiotics
MaaT013, a Microbiome Ecosystem Therapy™ (MET), is designed to restore the gut microbiome in pediatric patients aged 6 to 18 years with steroid-resistant aGvHD.
Researchers have developed a new approach to restore the gut microbiota by combining a high-fiber, plant-based diet with supplementation of beneficial microbes such as Limosilactobacillus reuteri.
Probiotics such as Lactobacillus can complement breast cancer therapy to improve prevention and treatment.
Nigel Titford, CEO at Biogaia Pharma, discusses the strategic considerations and challenges involved in working across both the dietary supplement and pharmaceutical sectors.
Industry
Sponsored by
In July 2024, the journal Frontiers in Microbiology presented a groundbreaking method that overcomes this hurdle: the Flow-FISH method.
Industry
Sponsored by
Probiotic intervention in the gut–prostate axis with novaPROX combo: insights from an in vitro study
The study published on Foods Journal researched the mechanisms of action of Probionova's novaPROX product using a 3D intestinal barrier model and a co-culture prostatic model.
On the second anniversary of its launch, Ferring Pharmaceuticals’ REBYOTA remains a landmark innovation in the prevention of recurrent Clostridioides difficile.
Lonza's capsules ensures targeted intestinal delivery enhancing stability and therapeutic efficacy for LBPs and pharmaceutical applications.
Cmbio announces a strategic partnership with Nimble Science to deliver first in class high-quality, multi-omic data insights from the small intestine.
Its emergence in the respiratory health sector represents a paradigm shift, offering promising avenues for innovation and investment.
